Astera Labs (NASDAQ:ALAB) Shares Down 1.3% on Insider Selling

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price was down 1.3% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $303.00 and last traded at $341.70. Approximately 7,296,222 shares changed hands during trading, an increase of 31% from the average daily volume of 5,557,831 shares. The stock had previously closed at $346.33.

Specifically, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $3,276,963.90. Following the sale, the director owned 5,292 shares of the company’s stock, valued at $1,928,140.20. This trade represents a 62.96% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the transaction, the director directly owned 60,134 shares of the company’s stock, valued at $21,909,822.90. This trade represents a 5.51% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ALAB. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Royal Bank Of Canada increased their price objective on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Loop Capital assumed coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Finally, Morgan Stanley upped their target price on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $233.75.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs remains a favored AI infrastructure name, with recent commentary highlighting strong Q1 results, constructive guidance, and momentum in products tied to AI connectivity and data-center demand. Astera Labs jumps 9.4% as investors digest strong Q1 results and conference commentary
• Positive Sentiment: Some market watchers still describe ALAB as an early-stage AI growth story, which can help support investor interest in the stock despite its sharp run-up. Astera Labs: Still An Early AI Story
• Neutral Sentiment: Institutional and analyst activity remains constructive overall, with multiple firms maintaining buy or outperform-type ratings and several large investors adding shares in recent quarters.
• Neutral Sentiment: Astera Labs shareholders also approved director and governance measures at the annual meeting, a routine corporate update that is unlikely to move the stock much on its own. Astera Labs Shareholders Approve Directors and Governance Measures
• Negative Sentiment: Bearish commentary has warned that the stock’s rapid rally has made valuation look stretched, raising the risk of a further pullback if growth expectations cool. Soaring Astera Labs stock faces a major valuation risk: what next?
• Negative Sentiment: Director Jack Lazar sold 10,000 shares worth about $3.6 million, adding to investor caution around insider selling, even though the trade was made under a pre-arranged 10b5-1 plan. Astera Labs (NASDAQ:ALAB) Director Sells $3,551,700.00 in Stock
• Negative Sentiment: A recent downgrade from Seeking Alpha and other cautious writeups suggest some investors are taking profits after the sharp move higher. Astera Labs: Take Some Chips Off The Table (Rating Downgrade)

Astera Labs Stock Performance

The stock’s 50 day simple moving average is $217.60 and its 200 day simple moving average is $173.27. The firm has a market cap of $58.57 billion, a PE ratio of 230.88, a PEG ratio of 4.20 and a beta of 3.94.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Royal Bank of Canada raised its position in Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC lifted its stake in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its holdings in Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares during the period. First Trust Advisors LP increased its stake in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the period. Finally, Brown Advisory Inc. lifted its position in Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.